Study: Outpatient parenteral antimicrobial therapy leads to few C. diff infections

Patients who received outpatient parenteral antimicrobial therapy experienced low rates of Clostridium difficile infections, according to findings reported at IDWeek 2014.

Researchers analyzed the charts of more than 2,000 adult patients discharged with community outpatient parenteral antimicrobial therapy from 2013 to 2014.

Of those patients, just five (0.73 percent) developed community onset C. difficile. All five of these patients had a recent exposure to a healthcare facility. Two of the five patients had hospital readmissions not related to the C. difficile infection, and four of the five were on concomitant acid suppressive therapy, according to the study.

Researchers indicate that hospital exposure and antimicrobial therapy are risk factors for developing C. difficile.

More articles on C. difficile:

Cubist reports positive preliminary results with C. diff drug
C. diff rates soar over 10 years
C. diff increases mortality risk in cirrhosis patients

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>